Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marija Balic

Showing results (21-30 of 121) with videos related to

Pageof 13
Sort By:
Breast Care (Basel, Switzerland)|October 16, 2018
News from ASCO 2018Marija Balic, Natalija Dedic, Leticia De Mattos-Arruda, et al.
Breast Care (Basel, Switzerland)|August 9, 2017
Biosimilars in the Treatment of Breast CancerMarija Balic, Rupert Bartsch, Thomas Bauernhofer, et al.
Annual Review of Medicine|October 25, 2012
Circulating tumor cells: from bench to bedsideMarija Balic, Anthony Williams, Henry Lin, et al.
Breast Care (Basel, Switzerland)|May 20, 2021
Expert Discussion: Immunotherapy in Breast Cancer - Ready for Prime Time?Gabriel Rinnerthaler, Volkmar Müller, Marija Balic, et al.
Critical Reviews in Oncology/Hematology|June 24, 2010
Disseminated and circulating tumor cells: Role in effective cancer managementHenry Lin, Marija Balic, Siyang Zheng, et al.
Expert Review of Molecular Diagnostics|April 4, 2012
Progress in circulating tumor cell capture and analysis: implications for cancer managementMarija Balic, Henry Lin, Anthony Williams, et al.
Journal of Clinical Immunology|October 17, 2007
Resistance to apoptosis and expansion of regulatory T cells in relation to the detection of circulating tumor cells in patients with metastatic epithelial cancerStefanie Stanzer, Nadia Dandachi, Marija Balic, et al.
Journal of Computer Assisted Tomography|February 15, 2019
Volume Computed Tomography Perfusion Imaging: Evaluation of the Significance in Oncologic Follow-up of Metastasizing Renal Cell Carcinoma in the Early Period of Targeted Therapy - Preliminary ResultsAida Vehabovic-Delic, Marija Balic, Christopher Rossmann, et al.
Wiener Klinische Wochenschrift|September 8, 2023
Updated Austrian treatment algorithm for metastatic triple-negative breast cancerRupert Bartsch, Gabriel Rinnerthaler, Edgar Petru, et al.
American Journal of Clinical Pathology|September 19, 2007
The predictive value of EGFR and HER-2/neu in tumor tissue and serum for response to anthracycline-based neoadjuvant chemotherapy of breast cancerWalter Schippinger, Nadia Dandachi, Peter Regitnig, et al.
Pageof 13

Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
Breast Care (Basel, Switzerland)|October 16, 2018
News from ASCO 2018Marija Balic, Natalija Dedic, Leticia De Mattos-Arruda, et al.
Breast Care (Basel, Switzerland)|August 9, 2017
Biosimilars in the Treatment of Breast CancerMarija Balic, Rupert Bartsch, Thomas Bauernhofer, et al.
Annual Review of Medicine|October 25, 2012
Circulating tumor cells: from bench to bedsideMarija Balic, Anthony Williams, Henry Lin, et al.
Breast Care (Basel, Switzerland)|May 20, 2021
Expert Discussion: Immunotherapy in Breast Cancer - Ready for Prime Time?Gabriel Rinnerthaler, Volkmar Müller, Marija Balic, et al.
Critical Reviews in Oncology/Hematology|June 24, 2010
Disseminated and circulating tumor cells: Role in effective cancer managementHenry Lin, Marija Balic, Siyang Zheng, et al.
Expert Review of Molecular Diagnostics|April 4, 2012
Progress in circulating tumor cell capture and analysis: implications for cancer managementMarija Balic, Henry Lin, Anthony Williams, et al.
Journal of Clinical Immunology|October 17, 2007
Resistance to apoptosis and expansion of regulatory T cells in relation to the detection of circulating tumor cells in patients with metastatic epithelial cancerStefanie Stanzer, Nadia Dandachi, Marija Balic, et al.
Journal of Computer Assisted Tomography|February 15, 2019
Volume Computed Tomography Perfusion Imaging: Evaluation of the Significance in Oncologic Follow-up of Metastasizing Renal Cell Carcinoma in the Early Period of Targeted Therapy - Preliminary ResultsAida Vehabovic-Delic, Marija Balic, Christopher Rossmann, et al.
Wiener Klinische Wochenschrift|September 8, 2023
Updated Austrian treatment algorithm for metastatic triple-negative breast cancerRupert Bartsch, Gabriel Rinnerthaler, Edgar Petru, et al.
American Journal of Clinical Pathology|September 19, 2007
The predictive value of EGFR and HER-2/neu in tumor tissue and serum for response to anthracycline-based neoadjuvant chemotherapy of breast cancerWalter Schippinger, Nadia Dandachi, Peter Regitnig, et al.
Pageof 13